Health Condition 1: I39- Endocarditis and heart valve disorders in diseases classified elsewhere Health Condition 2: I999- Unspecified disorder of circulatory system
Conditions
Interventions
Intervention1: Transversus Thoracic Muscle Plane Block: Group TTMPB will receive 20mL of 0.5% ropivacaine on each side of sternum + LA infiltration (10ml, 0.5% ropivacaine) around chest tubes half an
Sponsors
Dr Monika Soni
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA physical status 2 or 3 2. Patients able to comprehend and willing to participate. 3. Patients scheduled for elective on pump cardiac surgery requiring median sternotomy.
Exclusion criteria
Exclusion criteria: 1. Patients refusal to participate 2. Patients with left venticular ejection fraction less than 30% 3. Emergent or redo surgeries 4. Studied drug allergy 5. Hematological disease or h/o bleeding diathesis 6. Chronic Opioids use 7. Severe organ dysfunction (Renal/ Liver insufficiencies).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of recovery, using the Quality of Recovery- 15 (QoR- 15) scale at 24 h post- operativelyTimepoint: At 24 h post- operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess pain score using NRS scale upto 24 hr, time to first rescue analgesia use, total analgesic consumption upto 24 hr, patients satisfaction and any adverse effects seen.Timepoint: pain score will be recorded at rest and during coughing using NRS scores at 0, 3, 6, 12, 18 and 24 hours. | — |
Countries
India
Contacts
Public ContactDr Alok Kumar Bharti
Indira Gandhi Institute of Medical Sciences
Outcome results
None listed